Aclaris Therapeutics Announces Issuance of Additional Orange Book Listable Patent Covering RHOFADE® (Oxymetazoline Hydrochloride) Cream, 1% July 9, 2019 - NASDAQ Companies 0 » View More News for July 09, 2019
